Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer

François Vaillant , Delphine Merino , Lily Lee , Kelsey Breslin
Cancer Cell 24 ( 1) 120 -129

186
2013
RUNX2 Mediates Plasmacytoid Dendritic Cell Egress from the Bone Marrow and Controls Viral Immunity

Michaël Chopin , Simon P. Preston , Aaron T.L. Lun , Julie Tellier
Cell Reports 15 ( 4) 866 -878

25
2016
Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2.

Bhupinder Pal , Toula Bouras , Wei Shi , François Vaillant
Cell Reports 3 ( 2) 411 -426

97
2013
Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage

Andrea Sau , Rosanna Lau , Miguel A. Cabrita , Emma Nolan
Cell Stem Cell 19 ( 1) 52 -65

51
2016
Homeobox Genes in Hematopoiesis

A Elefanty , A Perkins , A Harris , J Visvader
Experimental Hematology 20 ( 6) 796 -796

1992
LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.

M E Montañez-Wiscovich , D D Seachrist , M D Landis , J Visvader
Oncogene 28 ( 41) 3608 -3618

40
2009
Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins.

L J Ransone , J Visvader , P Sassone-Corsi , I M Verma
Genes & Development 3 ( 6) 770 -781

129
1989
336
1988
Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.

J Visvader , I M Verma
Molecular and Cellular Biology 9 ( 3) 1336 -1341

79
1989
Regulation of fos gene: a paradigm for nuclear oncogenes

IM Verma , J Visvader , WW Lamph , P DeTogni
UCLA Symp. Mol. Cell. Biol 87 129 -149

5
1988
SUPPRESSOR OF CYTOKINE SIGNALING 5 LOSS PROMOTES BREAST CANCER

E Linossi , L Dagley , T Kolesnik , M-L Asselin-Labat
CYTOKINE 87 62 -62

2016
1
1995
LMO4 and LDB1: a transcriptional complex

JE Deane , JP Mackay , JM Matthews , J Visvader
Proceedings of the Australian Society for Biochemistry and Molecular Biology 33 POS1 -006

2001
INVESTIGATION OF STEM AND PROGENITOR SUBPOPULATIONS IN HUMAN BREAST TISSUE FROM BRCA1 AND BRCA2 CARRIERS: 124

E Lim , F Vaillant , N Forrest , B Pal
Asia-pacific Journal of Clinical Oncology 4

2008
Print C, Bath ML, Huang DC, Strasser A (2000)

LA O’Reilly , L Cullen , J Visvader , GJ Lindeman
Am. J. Pathol 157 449 -461

29
Genetic, histopathological and functional analysis of unclassified variants of BRCA1 and BRCA2.

G Chenevix-Trench , A Spurdle , M Brown , P Lovelock
BREAST CANCER RESEARCH AND TREATMENT 88 S156 -S156

2004